The association did not reach statistical significance in the first-line therapy, multiple tumors, AFP ≥ 400 ng/mL, or BCLC stage B subgroups (all P for interaction > 0.05; Figure 4 ).
← all excerpts
Post-Treatment Prognostic Nutritional Index Outperforms Baseline Index as an Independent Prognostic Biomarker in Advanced Hepatocellular Carcinoma Receiving Immune-Based Systemic Therapy.
1
—
—